Reproterol

This classification denotes a metaproterenol analog, adrenergic beta-agonists, and bronchodilator agent with the molecular formula C18H23N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 11941YC6RN, chemically known as 1,2,3,6-tetrahydro-1,3-dimethyl-7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)-2,6-purindion but generally known as reproterol, which bears US NIH Compound Identifier 25654. European Medicines Agency schedules Reproterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10283MIG. World Health Organization schedules reproterol in its Anatomical Therapeutic Chemical (ATC) Classification. REPROTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule reproterol under HS 29395900 and SITC 54145. As of Q4 2014, REPROTEROL remains the US FDA Preferred Term for this commodity. SMILES: OC(CNCCCN1C2C(N(C(=O)N(C2=O)C)C)NC1)C1CC(O)CC(O)C1.